PYC THERAPEUTICS LIMITED — Director's Dealing 2016

Nov 29, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We, Phylogica Limited, give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	STEPHANIE UNWIN
Date of last notice	18 JANUARY 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	DIRECT	DIRECT	DIRECT
	Nature of indirect interest
	(inNotethe	cluding registered holder): Provide details of the circumstances gelevant interest	iving rise to
		.
	Da	te of change		29 NOVEMBER 2016
	No	. of securities heldprior to	**change **	NIL
	Cl			UNLISTED OPTIONS
		ss
	Nu	mber acquired		10,000,000
	Na	ture of change		ISSUED SUBSEQUENT TO SAPPROVAL RECEIVED 29 N	HAREHOLDERVEMBER 2016
	Exaoptiplan	mple: on-market trade, off-market trade,ons, issue of securities under dividend r, participation in buy-back	exercise ofeinvestment		.
	Nu	mber disposed		NIL
	VaNoteesti	lue/Consideration: If consideration is non-cash, provideated valuation	details and	ISSUED FREE
	No	. of securities held after ch	ange	DIRECT
				10,000,000 UNLISTED OPTIONOVEMBER 2019 NIL EXER	NS EXPIRY 30CISE PRICE
Par		t 2 – Chane of direct	r’s interests in contracts
Note:		gIn the case of a company, interests whic	h come within paragraph (ii) of the definition of “notifiable interes		t of a director” should be
disclo		sed in this part.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where priorwritten clearance was required?	NO
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what datewas this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We, Phylogica Limited, give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	PAUL WATT
Date of last notice	12 SEPTEMBER 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise tothe relevant interest.	MARIA DEL PILAR ENRIQUEZ‐WATTWife
Date of change	14 OCTOBER 2016
No. of securities held prior to change	DIRECT- 4,044,123 ORDINARY SHARESINDIRECTPAUL MICHAEL WATT & MARIA DEL PILARENRIQUEZ-WATT ATF THE BRAINCHILD SUPERFUNDTrustee & Fund Beneficiary- 10,473,074 ORDINARY SHARESMARIA DEL PILAR ENRIQUEZ‐WATTWife- 9,000,000 ORDINARY SHARES
Class	UNLISTED OPTIONS
Number acquired	20,000,000
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestmentplan, participation in buy-back	ISSUED SUBSEQUENT TO SHAREHOLDERAPPROVAL RECEIVED 25 NOVEMBER 2016

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Number disposed	NIL
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation		ISSUED FREE
No. of securities held after change		DIRECT- 4,044,123 ORDINARY SHARESINDIRECTPAUL MICHAEL WATT & MARIA DEL PILARENRIQUEZ-WATT ATF THE BRAINCHILD SUPERFUNDTrustee & Fund Beneficiary- 10,473,074 ORDINARY SHARESMARIA DEL PILAR ENRIQUEZ‐WATTWife
		- 9,000,000 ORDINARY SHARES- 20,000,000 UNLISTED OPTIONS EXPIRY 30
		JUNE 2018, NIL EXERCISE PRICE

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed	NO
above traded during a+closed period where prior
written clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date	N/A
was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011